Related references
Note: Only part of the references are listed.Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study
A. Peguero et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine A Real-World Study
Lisa Antonia Droge et al.
HYPERTENSION (2021)
Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
Xuming Bian et al.
HYPERTENSION (2019)
Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring
Rachael Fox et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Hypertensive Disorders of Pregnancy ISSHP Classification, Diagnosis, and Management Recommendations for International Practice
Mark A. Brown et al.
HYPERTENSION (2018)
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
Dietmar Schlembach et al.
BMC HEALTH SERVICES RESEARCH (2018)
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Harald Zeisler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia
Harald Zeisler et al.
OBSTETRICS AND GYNECOLOGY (2016)
sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK
M. Vatish et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
8 The sFlt-1/PLGF ratio can rule out preeclampsia for up to four weeks in women with suspected preeclampsia
Stefan Verlohren et al.
Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health (2016)
Implementation of the sFlt-1/PIGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice
H. Stepan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2015)
Care-as-usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome
Denise H. J. Delahaije et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol
Martin Hund et al.
BMC PREGNANCY AND CHILDBIRTH (2014)
Global and regional estimates of preeclampsia and eclampsia: a systematic review
Edgardo Abalos et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Angiogenic Factors and Preeclampsia
Sharon E. Maynard et al.
SEMINARS IN NEPHROLOGY (2011)
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
Leanne Bellamy et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Management of pre-eclampsia
L Duley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
T Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Maternal serum sFIt1 concentration is an early and reliable predictive marker of preeclampsia
A Hertig et al.
CLINICAL CHEMISTRY (2004)
Evidence supporting a rote for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia -: Young Investigator Award
T Chaiworapongsa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
K Koga et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Share Paper
